The potential role of nitric oxide in cardiovascular safety when treating patients with osteoarthritis and hypertension: a moderated panel discussion.
White
William B
WB
Division of Hypertension and Clinical Pharmacology, Pat and Jim Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington, Connecticut 06030-3940, USA. wwhite@nso1.uchc.edu
Pepine
Carl J
CJ
Weber
Michael A
MA
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism*; D009569:Nitric Oxide / Q000008:administration & dosage / Q000378:metabolism*; D020030:Nitric Oxide Donors / Q000627:therapeutic use; D010003:Osteoarthritis / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D020030:Nitric Oxide Donors; D009569:Nitric Oxide